… of over 150 patients treated with semustine and or carmustine, all … following hematopoetic
stem cell transplantation (HSCT). … in the primary endpoint of dialysis independence at 3 months …

… autologous stem cell collection and a stem cell transplant (1). Prior to an autologous stem cell
transplant… time to collection of autologous hematopoietic stem cells is 10-12 days following …

… acute rejection within the first year post-heart transplantation (… those with chronic kidney
disease or end-stage heart failure. … who were conditioned with carmustine, etoposide, cytarabine, …

… and assessment of renal response after treatment (Objective 1)… and autologous stem cell
transplant (ASCT) (Objective 2); … PPCN and with BEAM (carmustine, etoposide, cytarabine, and …

… Autologous hematopoietic stem cell transplantation (HSCT) is … occur after a single dose or
more commonly after accumulated … to months or occasionally years after treatment, although …

… Our objective is to publish these two articles which form the chapters of the PhD, after the
extension of the patent which has been filed in august 2018 on the results obtained during this …

… followed by autologous stem cell transplantation. However, … was primarily a combination
of carmustine, etoposide (VP16), … patients only who achieved CR after first line MTX-based …

… , and etoposide (PACE) combined with stem cell transplant (… and had a complicated hospital
course following the initiation of … failure, sepsis, encephalopathy, and acute kidney injury …

… after allogeneic hematopoietic stem cell transplantation ..........… hematopoietic lineages after
autologous hematopoietic stem … in patients with chronic kidney disease, demonstrating similar …

… rejection after transplant, may cause lung injury that in some cases … of solid organ and
hematopoietic stem cell transplants. Organizing … Etoposide is rarely toxic but can produce a severe …